(Q36349422)

13 August 2017

1 reference

title

Mitochondrial mechanisms of neurotoxicity (English)

1 reference

13 August 2017

1 reference

Nicklas WJ

1

1 reference

13 August 2017

Saporito M

2

1 reference

13 August 2017

Basma A

3

1 reference

13 August 2017

Geller HM

4

1 reference

13 August 2017

Heikkila RE

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 1992

1 reference

Annals of the New York Academy of Sciences

13 August 2017

published in

1 reference

13 August 2017

volume

648

1 reference

13 August 2017

page(s)

28-36

1 reference

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by 1-methyl-4-phenylpyridinium (MPP+) analogs and their energized accumulation by mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24521.X

10.1111/J.1749-6632.1992.TB24521.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference